LEWIS-BASE ADDUCTS OF LEAD (11) COMPLEXES. CRYSTAL STRUCTURES OF Pb (BIPY) (H O) (N0 ) AND Pb (PHEN) (H 0) (NO )

Authors: not saved
Abstract:

Reactions of equemolar amounts of lead (II) nitrate and 2,2'- bipyridine o r l , 10- phenanthroline in aqueous methanolicsolution yield crystals of Pb (bipy)(H O)(NO ) (1) or Pb (phen) (H O) (NO ) (2) respectively. Their structures were determined by X-ray crystallography. The method and structure determination is described

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

LEWIS BASE ADDUCTS OF LEAD(I1) COMPOUNDS IV*, SYNTHESIS AND CRYSTAL STRUCTURES OF (DINITRATO) (1,4,8,11- TETRA- AZAANDECANE) LEAD(I1)

The synthesis and single-crystal X-ray structure determination of the title compound (dinitrato) (1,4,8,11 -tetra-azaandecane) lead(II) is described. Crystals are monoclinic, P2 /ca= 10.271 (2)?,b= 13.524(4) ?,c= 11.298(6) ?,?=94.68(3),2=4,R,Rw, 0.036 and 0.041, respectively. The lead atom is eight-coordinate [Pb-N, 2.44 (2) - 2.55 (1)], [Pb-0,2.87 (1) - 3.06 (2)].

full text

LEWIS-BASE ADDUCTS OF LEAD(II) COMPOUNDS VI.* SYNTHESIS AND STRUCTURAL CHARACTERIZATION OF MONONUCLEAR (DIACETATO-0,O ')(1, 10-PHENANTHROLINE)

The synthesis and single-crystal X-ray structure determination of the title compound (phen)Pb(02CMe) is described. The complex crystallizes in the monoclinic space group P2 /c, a = 7.823(3), b = 12.421(4), c = 9.262(2) ?, ? = 79.92(3)", Z = 4, yielding R 0.048 for 3210 independent reflections. The coordination number around the lead atom is six. [Pb-N 2.54(2), 2.56(4)],[Pb-0, 2.19-2.22]

full text

LEWIS-BASE ADDUCTS OF LEAD(II) COMPOUNDS V,* SYNTHESIS AND STRUCTmAL CHARACTEREATION OF MONONUCLEAR (ACETATO-0,O') BIS(2,Zr-BIPYRIDINE) (PERCHLORATO-0,O') LEAD(II) AND BIS (2,Z'-BIPYRIDIW) BIS(PERCHL0RATO-0,O') LEAD(II)

The synthesis and single-crystal X-ray structure determination of the title compound [(bipy) , Pb(0 ,CMe) (O ClO )] (1) and [(bipy) Pb(ClO ) ] (2) is described. Compound (I) crystallizes in the triclinic space group P1(2), a= 7.384(2), b= 12.824(3), c= 10.622(6) A, ?= 73.41(2), ?= 80.98(2), ?= 73.68(2)', Z= 2, and R =0.033 for 3408 independent reflections .Compound (2) crystallizes in the ...

full text

lewis base adducts of lead(i1) compounds iv*, synthesis and crystal structures of (dinitrato) (1,4,8,11- tetra- azaandecane) lead(i1)

the synthesis and single-crystal x-ray structure determination of the title compound (dinitrato) (1,4,8,11 -tetra-azaandecane) lead(ii) is described. crystals are monoclinic, p2 /ca= 10.271 (2)?,b= 13.524(4) ?,c= 11.298(6) ?,?=94.68(3),2=4,r,rw, 0.036 and 0.041, respectively. the lead atom is eight-coordinate [pb-n, 2.44 (2) - 2.55 (1)], [pb-0,2.87 (1) - 3.06 (2)].

full text

COMPLEXES OF LEAD (II)*: CRYSTAL STRUCTURES OF L2Pb (NO,), AND L2Pb(SCN), L=Z(AMINOMETHYL) PYRIDINE

The reactions of Pb(N0 ) and Pb(SCN)2 with 2-(aminomethy1)pyridine (C H N = L) yielded colourless crystals of L Pb(N0 ) ( I ) and L Pb(SCN) , (2), respectively. Their structures were determined by X-ray crystallography. Crystal data: 1, monoclinic, P2 /c, a = 9.263 (4) ?, b = 7.783 (2) ?, c = 6.692 (3) ?, ? = 101.26 (2)?, Z = 2, Mo K?, 1540 observed (I > 2.5 ?(I) data (22 ? C), R = 0...

full text

Two New Hemidirected Lead(II) Complexes: [Pb(pcih)(bha)] and [Pb(pcih)(NO3)]

Two new lead(II) complexes [Pb(pcih)(bha)] (1) and [Pb(pcih)(NO3)] (2, Hpcih = 1,4-bis(3-pyridyl)-2,3-diazo-1,3-butadiene, Hbha = 2-hydroxybenzoic acid) have been synthesized by solvothermal methods and structurally characterized. The single-crystal X-ray data show that the coordination spheres of the Pb2+ ions in 1 and 2 are hemidirected with stereochemically active electron lone pairs. There ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 1  issue 5

pages  -

publication date 1990-11-01

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023